Robert G Savage insider trades: Medicines (MDCO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
and 3 more companies
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 24, 2016 | MDCO | ↓ Sell | 10,000 | $36.95 | $370K | Direct | May 26, 2016 (2d) |
| Nov 13, 2015 | MDCO | ↓ Sell | 5,000 | $39.34 | $197K | Direct | Nov 16, 2015 (3d) |
| May 20, 2015 | MDCO | ↓ Sell10b5-1 | 15,000 | $26.78 | $402K | Direct | May 21, 2015 (1d) |
| Mar 16, 2015 | MDCO | ↓ Sell | 7,500 | $28.98 | $217K | Direct | Mar 18, 2015 (2d) |
| Mar 13, 2013 | MDCO | ↓ Sell | 3,750 | $31.77 | $119K | Direct | Mar 15, 2013 (2d) |
| Feb 20, 2013 | MDCO | ↓ Sell | 6,250 | $32.50 | $203K | Direct | Feb 21, 2013 (1d) |
| Jan 16, 2013 | MDCO | ↓ Sell | 11,250 | $30.00 | $338K | Direct | Jan 17, 2013 (1d) |
| Jan 8, 2013 | MDCO | ↓ Sell | 5,000 | $27.50 | $138K | Direct | Jan 10, 2013 (2d) |
| Aug 6, 2012 | MDCO | ↓ Sell | 10,000 | $24.94 | $249K | Direct | Aug 8, 2012 (2d) |
| Dec 13, 2007 | EPCT | ↑ Buy | 30,000 | $1.38 | $41K | Held in trust for child | Dec 14, 2007 (1d) |
| Aug 21, 2007 | EPCT | ↑ Buy | 22,100 | $1.59 | $35K | Direct | Aug 22, 2007 (1d) |
| Aug 21, 2007 | EPCT | ↑ Buy | 6,500 | $1.61 | $10K | Held in trust for child | Aug 22, 2007 (1d) |
| Aug 20, 2007 | EPCT | ↑ Buy | 5,500 | $1.57 | $9K | Held in trust for child | Aug 21, 2007 (1d) |
| Aug 20, 2007 | EPCT | ↑ Buy | 2,000 | $1.58 | $3K | Direct | Aug 21, 2007 (1d) |
| Aug 17, 2007 | EPCT | ↑ Buy | 4,000 | $1.57 | $6K | Direct | Aug 20, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert G Savage's insider trades
Robert G Savage is a director at Medicines (MDCO). Since Aug 17, 2007, Robert has reported 6 open-market purchases worth $105K and 9 sales worth $2.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (18% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (42 filings), option exercises (8 filings), other transactions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDCO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.